RMA-S cells were labeled with 1 mCi/ml51Crfor2 hrthen incubated with effector cells at 37C for 4 hr

RMA-S cells were labeled with 1 mCi/ml51Crfor2 hrthen incubated with effector cells at 37C for 4 hr.51Cr release in supernatants was measured with a -counter. survival and accumulation of virus-specific cytotoxic T lymphocytes. We conclude that pDCs mediate early antiviral IFN-I responses and influence the accrual of virus-specific NK or CD8+T cells in a virus-dependent manner. == Introduction == Plasmacytoid dendritic cells (pDCs) are bone marrow-derived leukocytes that secrete large amounts of type I interferons (IFN-I), i.e., IFN- and -, in response to a variety of viruses in vitro and in vivo (Gilliet et al., 2008). IFN-I confer resistance to viral infections and promote apoptosis of virally infected cells (Garca-Sastre and Biron, 2006;Honda et al., 2005c;Pestka et al., 2004). Moreover, IFN-I promote natural killer (NK) cell, dendritic cell (DC), T cell, and B cell functions (Banchereau and Pascual, 2006;Garca-Sastre and Biron, 2006;Kolumam et al., 2005;Le Bon and Tough, 2008). Thus, pDCs have been implicated in the control of both innate and adaptive host antiviral responses. Besides generating IFN-I, pDCs may contribute to antiviral defense through additional mechanisms. pDCs express major histocompatibility complex (MHC) molecules and costimulatory molecules, and therefore may directly present viral antigens to CD4+T cells and cross-present viral antigens to CD8+T cells (Villadangos and Young, 2008). In addition, pDCs are a INCB28060 source of proinflammatory chemokines, including CCL3, CCL4, CCL5, CXCL9, and CXCL10, which can attract activated CD4+and CD8+T cells to sites of contamination (Sozzani et al., 2010). pDCs also secrete interleukin-12 (IL-12), contributing to T helper 1 (Th1) cell polarization of CD4+T cells (Asselin-Paturel et al., 2001;Cella et al., 2000). Additionally, pDCs can directly kill virus-infected cells through FasL- and tumor necrosis factor-related apoptosis inducing ligand (TRAIL)-dependent mechanisms (Chaperot et al., 2006;Hardy et al., 2007). pDCs detect RNA and DNA viruses through two endosomal sensors, Toll-like receptors (TLR) 7 and TLR9, which induce secretion of IFN-I through the MyD88-interferon regulatory factor 7 (IRF7) signaling pathway (Blasius and Beutler, 2010;Honda et al., 2005a;Pichlmair and Reis e Sousa, 2007;Takeuchi and Akira, 2009;Thompson and Iwasaki, 2008). Viruses reach TLR7 and TLR9 via receptor-mediated endocytosis or transport of cytosolic replication intermediates into endosomes by autophagy (Thompson and Iwasaki, 2008;Wang et al., 2007). Numerous DNA and RNA INCB28060 viruses activate pDCs (Borrow and Bhardwaj, 2008;Cervantes-Barragan et al., 2007;Delale et al., 2005;Diebold et al., 2004;Jung INCB28060 et al., 2008;Krug et al., 2004a,2004b;Steinberg et al., 2009;Thompson and Iwasaki, 2008;Yoneyama et al., 2005;Zucchini et al., 2008) without the need for viral replication (Kumagai et al., 2009). Moreover, TLR7-, TLR9-, MyD88-, and IRF7-deficient mice fail to secrete sufficient IFN-I after certain viral infections, resulting in increased viral replication and mortality in comparison to wild-type mice (Delale et al., 2005;Honda et al., 2005b;Steinberg et al., 2009;Thompson and Iwasaki, 2008;Zucchini et al., 2008). However, it is not obvious whether pDCs are primarily responsible for TLR7- or TLR9-MyD88-IRF7-mediated antiviral responses in vivo. Moreover, whether pDCs impact the control of viral contamination via mechanisms other than IFN-I in vivo is usually poorly comprehended. One approach to assessing pDC functions in vivo is usually to analyze antiviral host responses in mice lacking pDCs. To this end, pDCs have been depleted by the administration of monoclonal antibodies specific for pDC surface antigens such as Gr-1 (Asselin-Paturel et al., 2001) or bone marrow stromal antigen 2 (BST-2) (Asselin-Paturel et al., 2003;Blasius et al., 2006b;Krug et al., 2004a). Although useful, one limitation of antibody (Ab) depletion studies is that the Gr-1 antigen (Ag) is usually expressed by pDCs, plasma cells (Wrammert et al., 2002), inflammatory monocytes (Barbalat et al., 2009), subsets of T cells (Walunas et al., 1995), and granulocytes. Moreover, the BST-2 Ag is usually expressed on pDCs and plasma cells in naive mice but is usually induced on most cell types after activation with IFN-I or IFN- (Blasius et al., 2006b). Therefore, pDC-depleting Abs can deplete additional cell types during viral contamination and the subsequent immune response, thus confounding the interpretation of these studies. An alternative approach to Ab depletion is usually to evaluate mutant mice Mouse monoclonal to CD34.D34 reacts with CD34 molecule, a 105-120 kDa heavily O-glycosylated transmembrane glycoprotein expressed on hematopoietic progenitor cells, vascular endothelium and some tissue fibroblasts. The intracellular chain of the CD34 antigen is a target for phosphorylation by activated protein kinase C suggesting that CD34 may play a role in signal transduction. CD34 may play a role in adhesion of specific antigens to endothelium. Clone 43A1 belongs to the class II epitope. * CD34 mAb is useful for detection and saparation of hematopoietic stem cells that are deficient for pDCs, specifically mice lacking the transcription factor E2-2 (Cisse et al., INCB28060 2008) or with.